Skip to content
Triangle logo TriangleGet started
← Study library

NCT03856437 · REGISTRY CONDITION SEARCH

A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination

Found through the registry condition index, not selected as a treatment recommendation. This discovery collection was restricted to studies with posted results.

Phase
NA
Status at capture
COMPLETED
Registry last update
2024-03-15

The goal of this study is to determine the effects of message framing (gain vs. loss) on African American parents' acceptance of the HPV vaccine and how such effects are moderated by parents' salient beliefs prior to message exposure. Participants are randomized into gain and loss conditions in which they view either gain-framed or loss-framed HPV vaccination messages. Key outcome variables include parents' attitudes and intentions toward vaccinating their children against HPV.

Open the original ClinicalTrials.gov record → · Download preserved record

What did the study report?

Outcomes, safety and baseline populations are separate source sections. Quality-of-life measures appear under their original outcome titles.

flow

Participant flow

→

baseline

Baseline characteristics

→

outcome · POSTED

Attitudes

→

outcome · POSTED

Intention to Vaccinate Free of Cost

→

outcome · POSTED

Intention to Vaccinate With Cost

→

adverse events

Adverse events

→

more info

Limitations, agreements, and source contact

→
Who could take part
eligibility Criteria
Inclusion Criteria: * 18 years or older * Self-identify as African American * Custodial parent or caretaker of at least one child under the age of 18 who has not been fully vaccinated against HPV. * Has access to Internet to complete the study Exclusion Criteria: * Younger than 18 years * Does not self-identify as African American * Not a custodial parent or caretaker of at least one child under the age of 18 who has not been fully vaccinated against HPV. * Has no access to Internet to complete the study
healthy Volunteers
true
maximum Age
99 Years
minimum Age
18 Years
sex
ALL
std Ages
  1. ADULT
  2. OLDER_ADULT
Treatment arms and interventions
arm Groups
  1. description
    Participants in this arm receive gain-framed HPV vaccination messages.
    intervention Names
    1. Behavioral: HPV vaccination messages
    label
    Gain-framed messages
    type
    EXPERIMENTAL
  2. description
    Participants in this arm receive loss-framed HPV vaccination messages.
    intervention Names
    1. Behavioral: HPV vaccination messages
    label
    Loss-framed messages
    type
    EXPERIMENTAL
  3. description
    Participants in this arm receive non-framed HPV vaccination messages.
    intervention Names
    1. Behavioral: HPV vaccination messages
    label
    Control messages
    type
    ACTIVE_COMPARATOR
interventions
  1. arm Group Labels
    1. Control messages
    2. Gain-framed messages
    3. Loss-framed messages
    description
    Digital multimedia messages consisting of text and imagery conveying the benefits of being vaccinated against HPV, the costs of not being vaccinated against HPV, or neither benefits or costs but simply a call for action.
    name
    HPV vaccination messages
    type
    BEHAVIORAL
Study design
allocation
RANDOMIZED
intervention Model
PARALLEL
masking Info
masking
NONE
primary Purpose
PREVENTION
Enrollment
count
1170
type
ACTUAL
Registered outcome plans (not posted results)
primary Outcomes
  1. description
    Attitudes toward HPV vaccination for children Scale range: 1-7 (higher score indicates more positive attitude) Subscales were averaged.
    measure
    Attitudes
    time Frame
    baseline posttest (test was approximately 5 minutes to complete)
  2. description
    Intention to have children vaccinated against HPV free of cost Scale range: 1-6 (higher score indicates stronger intention) Subscales were averaged.
    measure
    Intention to Vaccinate Free of Cost
    time Frame
    baseline posttest (test was approximately 5 minutes to complete)
secondary Outcomes
  1. description
    Intention to have children vaccinated against HPV free with cost Scale range: 1-6 (higher score indicates stronger intention) Subscales were averaged.
    measure
    Intention to Vaccinate With Cost
    time Frame
    baseline posttest (test was approximately 5 minutes to complete)
Full study description
brief Summary
The goal of this study is to determine the effects of message framing (gain vs. loss) on African American parents' acceptance of the HPV vaccine and how such effects are moderated by parents' salient beliefs prior to message exposure. Participants are randomized into gain and loss conditions in which they view either gain-framed or loss-framed HPV vaccination messages. Key outcome variables include parents' attitudes and intentions toward vaccinating their children against HPV.
detailed Description
The goal of this study is to determine the effects of message framing (gain vs. loss) on African American parents' acceptance of the HPV vaccine and how such effects are moderated by parents' salient beliefs prior to message exposure. Participants recruited from local communities and online panels will complete a computer-assisted survey. In the survey participants will first answer questions related to their beliefs about HPV and the HPV vaccine (e.g., perceived susceptibility, perceived severity, perceived efficacy, perceived safety, etc.), as well as other background information. Then they will be presented with either a gain-framed or loss-framed human papillomavirus vaccination message. After the message exposure, they will answer questions related to their attitudes toward HPV vaccination, intentions to vaccinate their children, as well as other message response measures. Eligible participants are at least 21 years old, self-identify as African American, and are custodial parents or caretakers of at least one child ages 9-17 who has not initiated the HPV vaccine series.
Source references
Source notices and limitations
    Discovery and provenance
    1. release id
      ctgov-registry-1336d216cbd1bbff780dac70
      edge id
      nct-edge-29a8c5265ce6ff7ac435
      requested nct id
      NCT03856437
      primary nct id
      NCT03856437
      source kind
      ctgov_condition_query
      source record id
      Source null
      source file sha256
      e9517ade36d469a7fd2e8b9c24ac926bac342fd6e763013a79e66e2d510f9bb7
      payload sha256
      d9fe5e4e5ca8661b9fbc908cf787540f810264f036a718657a56549baf9f9430
      payload
      clinical indication matching status
      condition_index_match_asserted_by_registry_not_reviewed
      end exclusive
      true
      id
      nct-edge-29a8c5265ce6ff7ac435
      link basis
      returned_by_explicit_condition_and_posted_results_filter_query
      nct id
      NCT03856437
      occurrences
      1. context exact
        NCT03856437
        end
        11
        exact text
        NCT03856437
        start
        0
      offset unit
      unicode_code_points
      query cond
      Penile Cancer
      query disease state id
      ds-penile-cancer
      source file
      /Users/arunverma/Documents/ChatGPT/Cancer Statistics Website/research-data/2026-09-10/clinicaltrials-condition/round-0000/raw/cond-penile-cancer-000.json
      source file sha256
      e9517ade36d469a7fd2e8b9c24ac926bac342fd6e763013a79e66e2d510f9bb7
      source json pointer
      /studies/7/protocolSection/identificationModule/nctId
      source kind
      ctgov_condition_query
      source record id
      Source null
      source string basis
      parsed_JSON_string_unmodified
      source string sha256
      d2d7515b8d6558b34e9856f96fecae7c48ae871c98f542c08f352ece708f9222

    Preserved source evidence · Not medical advice